Summary
Serum methotrexate levels were measured for 5 h after oral intake in 11 children with acute lymphoblastic leukaemia. The curves obtained with the child's regular dose of methotrexate varied widely, and were independent of the doses used. Peak levels were found in samples taken up to 3 h after ingestion, and ranged from 300 to 1250 ng/ml. In the doses used, methotrexate toxicity was present in one of the eleven children, and was associated with a delayed peak and a high 5-h methotrexate level. Individual drug metabolism could be an important factor in the response to treatment, and needs to be evaluated in the assessment of protocols.
Similar content being viewed by others
References
Aherne, G. W., Piall, E. M., Marks, V.: Development and application of a radioimmunoassay for methotrexate. Br. J. Cancer 36, 608–617 (1977)
Bender, R. A., Bleyer, W. A., Frisby, S. A., Oliverio, V. T.: Alteration of methotrexate uptake in human leukaemia cells by other agents. Cancer Res. 35, 1305–1313 (1975)
Capizzi, R. L.: Improvement in the therapeutic index of methotrexate (NSC-740) by l-asparaginase (NSC-109229). Cancer Chemother. Rep. 6, 37–41 (1975)
Chessells, J. M., Hardisty, R. M., Rapson, N. T., Greaves, M. F.: Acute lymphoblastic leukaemia in children: Classification and prognosis. Lancet 1977 II, 1307–1309
Craft, A. W., Kay, H. M., Lawson, D. N., McElwain, T. J.: Methotrexate induced malabsorption in children with acute lymphoblastic leukaemia. Br. Med. J. 1977 II, 151–152
Goldie, J. H., Price, L. A., Harrap, K. R.: Methotrexate toxicity: correlation with duration of administration, plasma levels, dose and excretion pattern. Eur. J. Cancer 8, 409–414 (1972)
Haghbin, M., Tan, C. C., Clarkson, B. D., Mike, V., Burchenal, J. H., Murphy, M. L.: Intensive chemotherapy in children with acute lymphoblastic leukaemia (L-2 protocol). Cancer 33, 1491–1498 (1974)
Hardisty, R. M., Till, M. M.: Acute leukaemia 1959–1964: Factors affecting prognosis. Arch. Dis. Child. 43, 107–115 (1968)
Harrap, K. R., Hill, B. T., Furness, M. E., Hart, L. I.: Mechanism of action of methotrexate: Intrinsic and acquired drug resistance. Ann. N.Y. Acad. Sci. 186, 312–324 (1971)
Hill, B. T., Baserga, R.: The cell cycle and its significance for cancer treatment. Cancer Treat. Rev. 2, 159–175 (1975)
Huffman, D. H., Wan, S. H., Azarnoff, D. L., Hoogstraten, B.: Pharmacokinetics of methotrexate. Clin. Pharmacol. Ther. 14, 572–579 (1973)
Hustu, H. O., Aur, R. J. A., Verzosa, M. S., Simone, J. V., Pinkel, D.: Prevention of central nervous system leukaemia by irradiation. Cancer 32, 585–597 (1973)
McLennan, I. C. M., Peto, J., Kay, H. E. M.: Analysis of treatment in childhood leukaemia. V. Advantage of reduced chemotherapy during and immediately after cranial irradiation. Br. J. Cancer 36, 625–633 (1977)
Mauer, A. M., Simone, J. V.: The current status of the treatment of childhood acute lymphoblastic leukaemia. Cancer Treat. Rev. 3, 17–41 (1976)
Medical Research Council: Treatment of acute lymphoblastic leukaemia: Effect of “prophylactic” therapy against central nervous system leukaemia. Br. Med. J. 1973 II, 381–384
Pinkel, D., Hernandez, K., borella, L., Holton, C., Aur, R., Samoy, G., Pratt, C.: Drug dosage and remission duration in childhood lymphocytic leukaemia. Cancer 27, 247–256 (1971)
Sheehy, P. F., Fried, J., Dowling, M. D., Clarkson, B. D.: Studies of cellular proliferation in human leukaemia. Cancer 36, 203–210 (1975)
Simone, J., Aur, R. J. A., Hustu, H. O., Pinkel, D.: “Total Therapy” studies of acute lymphocytic leukaemia in children. Cancer 30, 1488–1494 (1972)
Spiers, A. S. D., Roberts, P. D., Marsh, G. W., Parekh, S. J., Franklin, A. J., Galton, D. A. G., Szur, Z. L., Paul, E. A., Husband, P., Wiltshaw, E.: Acute lymphoblastic leukaemia: clinical chemotherapy with three combinations of four drugs (COAP-POMP-CART regimen). Br. Med. J. 1974 IV, 614–617
Wan, S. H., Huffman, D. H., Azarnoff, D. L., Stephans, R., Hoogstraten, B.: Effect of route of administration and effusions on methotrexate pharmacokinetics. Cancer Res. 34, 3487–3491 (1974)
Young, R. C., Chabner, B. A.: An in vivo method for monitoring differential effects of chemottherapy on target tissues in animals and man: correlation with plasma pharmacokinetics. J. Clin. Invest. 52, 92a (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kearney, P.J., Light, P.A., Preece, A. et al. Unpredictable serum levels after oral methotrexate in children with acute lymphoblastic leukaemia. Cancer Chemother. Pharmacol. 3, 117–120 (1979). https://doi.org/10.1007/BF00254982
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00254982